Respiratory Presentation of Pediatric Patients in the 2014 Enterovirus D68 Outbreak

Can Respir J. 2016:2016:8302179. doi: 10.1155/2016/8302179. Epub 2016 Aug 16.

Abstract

Background. In the fall of 2014, a North American outbreak of enterovirus D68 resulted in a significant number of pediatric hospital admissions for respiratory illness throughout North America. This study characterized the clinical presentation and risk factors for a severe clinical course in children admitted to British Columbia Children's Hospital during the 2014 outbreak. Methods. Retrospective chart review of patients with confirmed EV-D68 infection admitted to BCCH with respiratory symptoms in the fall of 2014. Past medical history, clinical presentation, management, and course in hospital was collected and analyzed using descriptive statistics. Comparison was made between those that did and did not require ICU admission to identify risk factors. Results. Thirty-four patients were included (median age 7.5 years). Fifty-three percent of children had a prior history of wheeze, 32% had other preexisting medical comorbidities, and 15% were previously healthy. Ten children (29%) were admitted to the pediatric intensive care unit. The presence of complex medical conditions (excluding wheezing) (P = 0.03) and copathogens was associated with PICU admission (P = 0.02). Conclusions. EV-D68 infection resulted in severe, prolonged presentations of asthma-like illness in the hospitalized pediatric population. Patients with a prior history of wheeze and preexisting medical comorbidities appear to be most severely affected, but the virus can also cause wheezing in previously well children.

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Infective Agents / therapeutic use
  • British Columbia / epidemiology
  • Calcium Channel Blockers / therapeutic use
  • Child
  • Child, Preschool
  • Continuous Positive Airway Pressure
  • Cough / etiology*
  • Cough / therapy
  • Disease Outbreaks
  • Dyspnea / etiology*
  • Dyspnea / therapy
  • Enterovirus D, Human
  • Enterovirus Infections / complications*
  • Enterovirus Infections / diagnostic imaging
  • Enterovirus Infections / epidemiology
  • Enterovirus Infections / therapy
  • Female
  • Humans
  • Hypoxia / etiology*
  • Hypoxia / therapy
  • Infant
  • Intensive Care Units, Pediatric / statistics & numerical data
  • Lung / diagnostic imaging
  • Magnesium Sulfate / therapeutic use
  • Male
  • Oxygen Inhalation Therapy
  • Radiography, Thoracic
  • Respiratory Sounds / etiology*
  • Respiratory Tract Infections / complications*
  • Respiratory Tract Infections / diagnostic imaging
  • Respiratory Tract Infections / epidemiology
  • Respiratory Tract Infections / therapy
  • Retrospective Studies
  • Seasons
  • Tachycardia / etiology*
  • Tachycardia / therapy
  • Tachypnea / etiology*
  • Tachypnea / therapy

Substances

  • Adrenal Cortex Hormones
  • Anti-Infective Agents
  • Calcium Channel Blockers
  • Magnesium Sulfate